All Industries

Top Life Sciences Companies

417 Life Sciences companies, sorted by total funding raised.

Basecamp Research

Builds evolutionary biological datasets and foundation AI models to design proteins and therapeut...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series B·$80.0M·Oct 2024
Fay

Fay is a three-sided AI platform connecting patients with registered dietitian nutritionists who ...

New York, United States51–200Life Sciences, Healthcare
Series B·$80.0M·Feb 2025
Mosanna Therapeutics

Improving the lives of patients with metabolic obstructive sleep apnea using a transformative app...

Redwood City, United States1–10Biotech, Sleep Apnea
Series A·$80.0M·Jun 2025
Zag Bio

Biotech company developing thymus-targeted bifunctional antibody therapies to restore immune tole...

Cambridge, United States11–50Biotech, Life Sciences
Series A·$80.0M·Oct 2025
Kala PharmaceuticalsIPO

Clinical-stage biopharma developing topical nanoparticle therapies for eye diseases, including tr...

Waltham, United StatesBiotech, Healthcare
Venture Round·$79.5M·Apr 2016
Spring

Mobile-first shopping marketplace connecting retailers directly to consumers, enabling brands to ...

New York, United StatesLife Sciences, E-Commerce
Series B·$79.3M·Sep 2021
Evermore

Provides a Smart Benefits platform and card connecting health plan members to retailers and servi...

Bentonville, United States51–200Life Sciences, Benefits Administration
Series B·$75.0M·Dec 2024
Georgiamune

Clinical-stage biotech developing immunotherapies that reprogram immune signaling to treat cancer...

Gaithersburg, United States11–50Life Sciences, Biotech
Series A·$75.0M·Aug 2023
ImmunocoreIPO

Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and auto...

Abingdon, Oxon, United KingdomHealthcare, Life Sciences
Series C·$75.0M·Jan 2021
Precision BioSciencesIPO

Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS geno...

Durham, United States51–200Biotech, Gene Editing
Venture Round·$75.0M·Jun 2022
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series E·$72.2M·Mar 2015
Cirsium Biosciences

We are a collective of innovators, researchers, and scientists committed to revolutionizing the g...

San Diego, United States11–50Life Sciences, Biotech
Grant·$71.6M·Oct 2024
Elysium

Develops clinically validated dietary supplements and biological-age tests to help consumers supp...

New York, United States11–50Life Sciences, Healthcare
Series C·$71.2M·Dec 2019
Vilya

Computational biotechnology company designing de novo macrocycles with AI for therapeutic drug di...

Seattle, United States11–50Artificial Intelligence, Biotech
Series A·$71.0M·Jun 2024
IL
Inventia Life Sciences

Pioneer in 3D cell culture technology through the RASTRUM platform and comprehensive Discovery Se...

Sydney, AustraliaBiotech, Life Sciences
Extension Round·$70.1M·Apr 2025
DEM Bio

DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immu...

Boston, United States11–50Life Sciences
Seed·$70.0M·Jun 2022
Homeward Health

Technology-enabled provider expanding access to primary and specialty care in rural America via l...

San Francisco, United States51–200Life Sciences, Digital Health
Series B·$70.0M·Aug 2022
Chamber Cardio

Platform that helps cardiology practices and payers deliver value-based cardiovascular care by al...

Washington, D.C.11–50Life Sciences, Digital Health
Series A·$68.0M·Feb 2026
Kernel

Builds non‑invasive neuroimaging hardware and software to measure and track brain health for clin...

Los Angeles, United States11–50Life Sciences, Artificial Intelligence
Series D·$67.3M·Dec 2023
AllStripesAcquired

Collects and structures patient medical records to generate regulatory‑grade real‑world evidence ...

San Francisco, United States51–200Data & Analytics, Healthcare
Series B·$67.0M·Aug 2021
ALGINOR

Sustainable future based on seaweed treasures from beyond the Arctic Circle.

Avaldsnes, Norway51–200Life Sciences
Venture Round·$65.2M·Jan 2024
Royalty PharmaIPO

Royalty Pharma is an innovative biopharma company with a portfolio of commercial and pre-commerci...

New York, United StatesHealthcare, Life Sciences
Venture Round·$60.0M·Jan 1996
CertifyOS

API-first provider data platform for health plans and digital health companies, automating creden...

New York, United States201–500Life Sciences, Data & Analytics
Series B·$59.0M·Jun 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Series A·$58.5M·Nov 2011
QUIBIM

QUantitative Imaging Biomarkers In Medicine. Transforming Medical Images into Actionable Predicti...

Valencia, Spain51–200Healthcare, Artificial Intelligence
Series A·$58.0M·Jan 2025